Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries

BMJ (Clinical research ed.)

Volumn 354, Issue , 2016, Pages i3903-

  Korhonen, Pasi ^a   Heintjes, Edith M ^a   Williams, Rachael ^a   Hoti, Fabian ^a   Christopher, Solomon ^a   Majak, Maila ^a   Kool Houweling, Leanne ^a   Strongman, Helen ^a   Linder, Marie ^a   Dolin, Paul ^a   Bahmanyar, Shahram ^a  

^a Takeda Global Research and Development Centre Europe   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; PIOGLITAZONE;

AGED; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; NETHERLANDS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SWEDEN; UNITED KINGDOM; URINARY BLADDER NEOPLASMS;

AGED; DATASETS AS TOPIC; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; NETHERLANDS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; THIAZOLIDINEDIONES; UNITED KINGDOM; URINARY BLADDER NEOPLASMS;

EID: 85016232505     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i3903     Document Type: Article

References (0)